Martin C. Hirsch

Prof. Dr. Martin C. Hirsch

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2021 in Journal of Medical Internet Research
Verified
Journal Article
Open access
SGStephen Gilbert
Stephen Gilbert
MFMatthew Fenech
Matthew Fenech
MHMartin C. Hirsch
Martin C. Hirsch
SUShubhanan Upadhyay
Shubhanan Upadhyay
ABAndrea Biasiucci
Andrea Biasiucci
JSJohannes Starlinger
Johannes Starlinger
One of the greatest strengths of artificial intelligence (AI) and machine learning (ML) approaches in health care is that their performance can be continually improved based on updates from automated learning from data. However, health care ML models are currently essentially regulated under provisions that were developed for an earlier age of slowly updated medical devices—requiring major documentation reshape and revalidation with every major update of the model generated by the ML algorithm. This creates minor problems for models that will be retrained and updated only occasionally, but major problems for models that will learn from data in real time or near real time. Regulators have announced action plans for fundamental changes in regulatory approaches. In this Viewpoint, we examine the current regulatory frameworks and developments in this domain. The status quo and recent developments are reviewed, and we argue that these innovative approaches to health care need matching innovative approaches to regulation and that these approaches will bring benefits for patients. International perspectives from the World Health Organization, and the Food and Drug Administration’s proposed approach, based around oversight of tool developers’ quality management systems and defined algorithm change protocols, offer a much-needed paradigm shift, and strive for a balanced approach to enabling rapid improvements in health care through AI innovation while simultaneously ensuring patient safety. The draft European Union (EU) regulatory framework indicates similar approaches, but no detail has yet been provided on how algorithm change protocols will be implemented in the EU. We argue that detail must be provided, and we describe how this could be done in a manner that would allow the full benefits of AI/ML-based innovation for EU patients and health care systems to be realized.

28 March 2022 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
FCFabienne Cotte
Fabienne Cotte
TMTobias Mueller
Tobias Mueller
SGStephen Gilbert
Stephen Gilbert
BBBibiana Blümke
Bibiana Blümke
JMJan Multmeier
Jan Multmeier
AJAndreas Jerrentrup
Andreas Jerrentrup
Background: Increasing use of emergency departments (EDs) by patients with low urgency, combined with limited availability of medical staff, results in extended waiting times and delayed care. Technological approaches could possibly increase efficiency by providing urgency advice and symptom assessments. Objective: The purpose of this study is to evaluate the safety of urgency advice provided by a symptom assessment app, Ada, in an ED. Methods: The study was conducted at the interdisciplinary ED of Marburg University Hospital, with data collection performed between August 2019 and March 2020. This study had a single-center cross-sectional prospective observational design and included 378 patients. The app’s urgency recommendation was compared with an established triage concept (Manchester Triage System [MTS]), including patients from the lower 3 MTS categories only. For all patients who were undertriaged, an expert physician panel assessed the case to detect potential avoidable hazardous situations (AHSs). Results: Of 378 participants, 344 (91%) were triaged the same or more conservatively and 34 (8.9%) were undertriaged by the app. Of the 378 patients, 14 (3.7%) had received safe advice determined by the expert panel and 20 (5.3%) were considered to be potential AHS. Therefore, the assessment could be considered safe in 94.7% (358/378) of the patients when compared with the MTS assessment. From the 3 lowest MTS categories, 43.4% (164/378) of patients were not considered as emergency cases by the app, but could have been safely treated by a general practitioner or would not have required a physician consultation at all. Conclusions: The app provided urgency advice after patient self-triage that has a high rate of safety, a rate of undertriage, and a rate of triage with potential to be an AHS, equivalent to telephone triage by health care professionals while still being more conservative than direct ED triage. A large proportion of patients in the ED were not considered as emergency cases, which could possibly relieve ED burden if used at home. Further research should be conducted in the at-home setting to evaluate this hypothesis. Trial Registration: German Clinical Trial Registration DRKS00024909; https://www.drks.de/drks_web/navigate.do? navigationId=trial.HTML&TRIAL_ID=DRKS00024909

11 November 2025 in JMIR Formative Research
Verified
Journal Article
Open access
AFAnna Fußhöller
Anna Fußhöller
FLFabian Lechner
Fabian Lechner
NSNadine Schlicker
Nadine Schlicker
FMFelix Muehlensiepen
Felix Muehlensiepen
AMAndreas Mayr
Andreas Mayr
JKJohannes Knitza
Johannes Knitza
Background: Large language models such as ChatGPT offer significant opportunities for medical education. However, empirical data on actual usage patterns, perceived benefits, and limitations among medical students remain limited. Objective: This study aimed to assess how medical students in Germany use ChatGPT, their perceptions of its educational value, and the challenges and concerns associated with its use. Methods: A cross-sectional 17-item online survey was conducted between May and August 2024 among medical students from Philipps University Marburg, Germany. A mixed methods approach was applied, combining descriptive and inferential statistical analysis with qualitative content analysis of open-ended responses. Results: A total of 84 fully completed surveys were included in the analysis (response rate: 26.7%; 315 surveys started). Overall, 76.2% (64/84) of the participants reported having used ChatGPT for medical education, with significantly higher usage during exam periods ( P =.003). Preclinical students reported higher overall usage than clinical students ( P =.02). ChatGPT was primarily used for summarizing information by 60.7% (51/84) of students, for literature research by 57.7% (49/84), and for clarifying concepts by 47.1% (40/84). A total of 70.2% (59/84) felt that it helped them save time, and 51.2% (43/84) reported an improved understanding of content. In contrast, only 31% (26/84) saw benefits for applying knowledge and 15.5% (13/84) for long-term knowledge retention. Qualitative responses highlighted clear benefits such as time savings and support in exam preparation, while also pointing to potential applications in clinical documentation and expressing concerns about misinformation and source transparency. However, 73.3% (55/75) expressed concerns about misinformation, and 72.6% (61/84) reported lacking confidence in their artificial intelligence (AI)–related skills. Only 41.7% (35/84) stated that they trust ChatGPT’s outputs. Students who used the tool more frequently also reported higher levels of trust in ChatGPT’s outputs ( r =0.374, P< .001). Over 70% of respondents indicated a strong desire for increased integration of AI-related education and practical applications within the medical curriculum. Conclusions: ChatGPT was already widely used among medical students, especially in exam preparation and the early stages of training. Students valued its efficiency and support for understanding complex material, but its long-term influence on learning is limited. Concerns about reliability, source transparency, and data privacy remain, and AI skills played a key role in shaping usage. These findings underscore the need to integrate structured, practice-oriented AI education into medical training to support critical, informed, and ethical use of large language models.

24 March 2022 in JMIR Formative Research
Verified
Journal Article
Open access
JTJoanna Timiliotis
Joanna Timiliotis
BBBibiana Blümke
Bibiana Blümke
PSPeter Daniel Serfözö
Peter Daniel Serfözö
SGStephen Gilbert
Stephen Gilbert
MOMarta Ondrésik
Marta Ondrésik
JEJens Eckstein
Jens Eckstein
Background: Continuously growing medical knowledge and the increasing amount of data make it difficult for medical professionals to keep track of all new information and to place it in the context of existing information. A variety of digital technologies and artificial intelligence–based methods are currently available as persuasive tools to empower physicians in clinical decision-making and improve health care quality. A novel diagnostic decision support system (DDSS) prototype developed by Ada Health GmbH with a focus on traceability, transparency, and usability will be examined more closely in this study. Objective: The aim of this study is to test the feasibility and functionality of a novel DDSS prototype, exploring its potential and performance in identifying the underlying cause of acute dyspnea in patients at the University Hospital Basel. Methods: A prospective, observational feasibility study was conducted at the emergency department (ED) and internal medicine ward of the University Hospital Basel, Switzerland. A convenience sample of 20 adult patients admitted to the ED with dyspnea as the chief complaint and a high probability of inpatient admission was selected. A study physician followed the patients admitted to the ED throughout the hospitalization without interfering with the routine clinical work. Routinely collected health-related personal data from these patients were entered into the DDSS prototype. The DDSS prototype’s resulting disease probability list was compared with the gold-standard main diagnosis provided by the treating physician. Results: The DDSS presented information with high clarity and had a user-friendly, novel, and transparent interface. The DDSS prototype was not perfectly suited for the ED as case entry was time-consuming (1.5-2 hours per case). It provided accurate decision support in the clinical inpatient setting (average of cases in which the correct diagnosis was the first diagnosis listed: 6/20, 30%, SD 2.10%; average of cases in which the correct diagnosis was listed as one of the top 3: 11/20, 55%, SD 2.39%; average of cases in which the correct diagnosis was listed as one of the top 5: 14/20, 70%, SD 2.26%) in patients with dyspnea as the main presenting complaint. Conclusions: The study of the feasibility and functionality of the tool was successful, with some limitations. Used in the right place, the DDSS has the potential to support physicians in their decision-making process by showing new pathways and unintentionally ignored diagnoses. The DDSS prototype had some limitations regarding the process of data input, diagnostic accuracy, and completeness of the integrated medical knowledge. The results of this study provide a basis for the tool’s further development. In addition, future studies should be conducted with the aim to overcome the current limitations of the tool and study design. Trial Registration: ClinicalTrials.gov NCT04827342; https://clinicaltrials.gov/ct2/show/NCT04827342

20 September 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
RIRobert Radu Ileșan
Robert Radu Ileșan
SSSebastian-Aurelian Stefaniga
Sebastian-Aurelian Stefaniga
RFRadu-Constantin Flesar
Radu-Constantin Flesar
MBMichel Beyer Michel Beyer
Michel Beyer Michel Beyer
EGElena Ginghina
Elena Ginghina
Paul FaragoPaul Farago
Paul Farago
Background: Parkinson’s disease (PD) has transitioned from a rare condition in 1817 to the fastest-growing neurological disorder globally. The significant increase in cases from 2.5 million in 1990 to 6.1 million in 2016, coupled with predictions of a further doubling by 2040, underscores an impending healthcare challenge. This escalation aligns with global demographic shifts, including rising life expectancy and a growing global population. The economic impact, notably in the U.S., reached $51.9 billion in 2017, with projections suggesting a 46% increase by 2037, emphasizing the substantial socio-economic implications for both patients and caregivers. Coupled with a worldwide demand for health workers that is expected to rise to 80 million by 2030, we have fertile ground for a pandemic. Methods: Our transdisciplinary research focused on early PD detection through running speech and continuous handwriting analysis, incorporating medical, biomedical engineering, AI, and linguistic expertise. The cohort comprised 30 participants, including 20 PD patients at stages 1–4 on the Hoehn and Yahr scale and 10 healthy controls. We employed advanced AI techniques to analyze correlation plots generated from speech and handwriting features, aiming to identify prodromal PD biomarkers. Results: The study revealed distinct speech and handwriting patterns in PD patients compared to controls. Our ParkinsonNet model demonstrated high predictive accuracy, with F1 scores of 95.74% for speech and 96.72% for handwriting analyses. These findings highlight the potential of speech and handwriting as effective early biomarkers for PD. Conclusions: The integration of AI as a decision support system in analyzing speech and handwriting presents a promising approach for early PD detection. This methodology not only offers a novel diagnostic tool but also contributes to the broader understanding of PD’s early manifestations. Further research is required to validate these findings in larger, diverse cohorts and to integrate these tools into clinical practice for timely PD pre-diagnosis and management.

14 July 2025 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PRPhilipp Russ
Philipp Russ
MMMuriel Morgenschweis
Muriel Morgenschweis
JEJonas Einloft
Jonas Einloft
HMHendrik L. Meyer
Hendrik L. Meyer
SBSimon Bedenbender
Simon Bedenbender
IGIvica Grgic
Ivica Grgic
Key Points: Virtual reality simulation provides a realistic training solution for medical emergencies. For the first time, we present the development of a virtual reality emergency simulation specifically for nephrology. Immersive virtual reality training may be an effective, cost-efficient tool for improving nephrology knowledge, skills, and patient care. Background: Medical emergencies require rapid assessment and prompt intervention. However, many medical students and early-career physicians often feel overwhelmed in these high-stakes situations, reporting limited exposure and inadequate preparation for real-life emergencies. Immersive technologies, such as virtual reality (VR), offer new avenues for realistic simulation. Recognizing the lack of comprehensive nephrologic emergency simulations, we sought to address this gap by designing a case focused on rapidly progressive GN (RPGN)—a prototypical nephrologic emergency requiring urgent treatment to prevent life-threatening complications. Here, we outline the conceptualization, step-by-step development, implementation, and assessment of learning outcomes. Methods: We developed and evaluated a de novo VR-training module focusing on AKI and hyperkalemia secondary to ANCA-associated vasculitis induced RPGN. The scenario features an interactive avatar patient and incorporates both standard clinical procedures and specialized nephrologic examinations. After initial development, we conducted a single-center pilot study with fifth-year medical students to assess its educational value and improve the prototype. The evaluation combined quantitative and qualitative feedback questionnaires, while learning success was assessed using a preintervention and postintervention knowledge test. Results: The study cohort comprised a total of 201 medical students with a mean age of 25.4 years (SD ±2.9). Analysis of student performance revealed variability in recognizing clinical findings. After history-taking, a noticeable shift in diagnostic reasoning emerged: the proportion of kidney-related differential diagnoses was higher, while that of cardiac-related diagnoses was lower accordingly. Furthermore, VR-based intervention resulted in a substantially higher participants' knowledge, evidenced by a 136% increase in mean test scores and a large effect size (Cohen d =2.22). Conclusions: We designed a VR scenario for evaluation of a patient who presents with AKI and hyperkalemia secondary to RPGN. Using this approach, trainees developed higher competence. This immersive technology provides an effective and cost-efficient tool for advancing clinical nephrology knowledge, skills, and engagement.